Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles.
Hepatitis C virus (HCV) infections are a major public-health concern. New antiviral drugs are needed urgently to complement and improve the efficacy of current chemotherapies. The morphogenesis of HCV represents an interesting, and still unexploited, novel molecular target. alpha-Glucosidase inhibit...
Main Authors: | Chapel, C, Garcia, C, Roingeard, P, Zitzmann, N, Dubuisson, J, Dwek, R, Trépo, C, Zoulim, F, Durantel, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Microbiology Society
2006
|
Similar Items
-
Inhibitors of alpha glucosidases impair HCV pseudoparticles morphogenesis, prevent viral secretion and entry into hepatoma cells
by: Chapel, C, et al.
Published: (2005) -
Alpha-glucosidases inhibitors impair HCV pseudoparticles morphogenesis, prevent viral secretion and entry into hepatoma cells
by: Chapel, C, et al.
Published: (2005) -
Inhibitors of alpha glucosidases impair HCV pseudoparticles morphogenesis, prevent viral secretion and entry into hepatoma cells
by: Chapel, C, et al.
Published: (2005) -
Virus morphogenesis and viral entry as alternative targets for novel hepatitis C antivirals
by: Chapel, C, et al.
Published: (2006) -
Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles
by: Chapel, C, et al.
Published: (2006)